Cabot earnings were $331.0M for the trailing 12 months ending Sep 30, 2025, with -10.6% growth year over year. The latest CBT earnings report on Sep 30, 2025 announced Q3 2025 earnings of $43.0M, down 57.4% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, CBT reported annual earnings of $331.0M, with -12.9% growth.
CBT past earnings growth
How has CBT's earnings growth performed historically?
On CBT's earnings call on Invalid Date, Cabot (NYSE: CBT) reported Q3 2025 earnings per share (EPS) of $0.80, up 67.35% year over year. Total CBT earnings for the quarter were $43.00 million. In the same quarter last year, Cabot's earnings per share (EPS) was $2.45.
As of the last Cabot earnings report, Cabot is currently profitable. Cabot's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $331.00 million, a 12.89% decrease year over year.
What was CBT's earnings growth in the past year?
As of Cabot's earnings date in Invalid Date, Cabot's earnings has grown -10.6% year over year. This is 12.66 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 2.06%. CBT earnings in the past year totalled $331.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.